-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SBRqUGSml2nrgMiHer8BmL0VHeZ12SmKCEGUvS2hpliyutadd7OnTGmSjw71NVd5 +KA3Xd3ArZP8In/oIaxYoQ== 0001157523-07-005358.txt : 20070518 0001157523-07-005358.hdr.sgml : 20070518 20070518095525 ACCESSION NUMBER: 0001157523-07-005358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070517 FILED AS OF DATE: 20070518 DATE AS OF CHANGE: 20070518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGER HARVEY J M D CENTRAL INDEX KEY: 0000932052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 07863242 BUSINESS ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a5406194_ex.xml X0202 4 2007-05-17 0 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0000932052 BERGER HARVEY J M D C/O ARIAD PHARMACEUTICALS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 1 0 0 Chairman & Chief Exec Officer Common Stock 2007-05-17 4 M 0 50000 3.875 A 465963 D Common Stock 2007-05-17 4 M 0 35000 1.375 A 501963 D Common Stock 2007-05-17 4 M 0 139455 .75 A 641418 D Employee Stock Option (Right to Buy) 3.875 2007-05-17 4 M 0 50000 0 A 2008-03-05 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 1.375 2007-05-17 4 M 0 35000 0 A 2009-05-05 Common Stock 35000 0 D Employee Stock Option (Right to Buy) .75 2007-05-17 4 M 0 139455 0 A 2009-10-04 Common Stock 139455 0 D Became exercisable 25% per year commencing 03/05/1999 Became exercisable 25% per year commencing 05/05/2000 Became exercisable 25% on date of grant and 25% per quarter for the subsequent three quarters Edward M. Fitzgerald Attorney-in-fact 2007-05-18 -----END PRIVACY-ENHANCED MESSAGE-----